Latest News
AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. - a US-based clinical-stage biopharmaceutical company that develops novel treatments for hypertension and chronic kidney disease. The acquisition will grow AstraZeneca’s cardiorenal pipeline by adding CinCor’s candidate drug, baxdrostat (CIN-107). The drug is an aldosterone synthase inhibitor (ASI) for blood pressure lowering in [...]
The US Food and Drug Administration (FDA) has approved lecanemab – a breakthrough drug for patients in the earliest stages of Alzheimer’s disease. Developed by Japanese companies Eisai and Biogen, the drug will be marketed in the US under the brand Leqembi. Lecanemab works by interacting with the immune system to clear clumps of amyloid [...]
Singing-based group rehabilitation can support communication and speech production in stroke patients, according to a recent study. Language function and the psychosocial wellbeing of patients and their families can be promoted with singing-based rehabilitation. Group intervention provides opportunities for peer support while being simultaneously cost effective. Approximately 40% of stroke survivors experience aphasia, a difficulty [...]
Could the AI algorithms behind ChatGTP help doctors detect Alzheimer’s disease?
Addison connects the patient with primary care, emergency response, friends and family.
The successful businesses will be supported by UK and Canadian experts.
NIH findings may provide early clues about increased risks for advanced biological ageing and premature death.
‘Single-cell profiling’ is helping neuroscientists see how disease affects major brain cell types and identify common, potentially targetable pathways. After decades of fundamental scientific and drug discovery research, Alzheimer’s disease has remained inscrutable and incurable, with a bare minimum of therapeutic progress. But in a new review article in Nature Neuroscience, MIT scientists write that [...]
A new machine learning-derived model could lead to better screening, diagnostics, and management of coronary artery disease. Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure [...]
Long-term care facilities should prioritise part-time employees in order to boost consistency of care, new research shows. In the United States, a multi-billion-dollar industry employs nurses and nursing assistants to provide long-term care in facilities such as nursing homes, residential care facilities, and home health agencies. A new study examined how these facilities — some [...]
